EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GenReP: An Ensemble Model for Predicting TP53 in Response to Pharmaceutical Compounds

Austin Spadaro, Alok Sharma iD, Iman Dehzangi

Molecules · 2026

DOI: 10.3390/molecules31040739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Austin Spadaro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational and Integrative Biology, Rutgers University, Camden, NJ 08102, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TP53 is a tumor-suppressor gene involved in regulating apoptosis, DNA repair, and genomic stability. Mutations in TP53 are implicated in approximately half of all detected cancers, including breast, lung, colorectal, and ovarian cancers, making it a significant target for therapeutic interventions. Many pharmaceutical drugs aim to restore TP53 function, and there is a need for predictive tools to assess how compounds may affect TP53 expression. In this study, we propose a new ensemble machine-learning model to predict the direction of TP53 relative gene expression in response to pharmaceutical compounds. Our model utilizes molecular fingerprints, descriptors, and scaffold-based features extracted from SMILES representations of compounds concatenated into a single feature vector. Trained using our newly generated benchmark dataset based on the Connectivity Map (CMap) database and addressing class imbalance with the Synthetic Minority Over-sampling Technique (SMOTE), our model achieves 62.9%, 93.9%, 40.3%, and 0.39 in terms of accuracy, sensitivity, specificity, and Matthews Correlation Coefficient (MCC), respectively. As the first-of-its-kind TP53 gene regulation prediction, our study serves as a convincing proof-of-concept that paves the way for future investigation. GenReP as a stand-alone predictor, its source code, and our newly generated benchmark dataset are publicly available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53HumansPrediction AlgorithmsEnsemble LearningMachine Learning

Stichwörter der Autor:innen

Connectivity MapTP53ensemble classifierfeature extractiongene expression

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Center for Computational and Integrative Biology, Rutgers University, Camden, NJ 08102, USA.
  • Institute for Integrated and Intelligent Systems, Griffith University, Brisbane, QLD 4111, Australia.
  • College of Informatics, Korea University, Seoul 02841, Republic of Korea.
  • Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
  • Department of Computer Science, Rutgers University, Camden, NJ 08102, USA.
  • Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ 08901, USA.

ORCID-Profile: Alok Sharma

Zitieren

APA

Spadaro, A., Sharma, A., & Dehzangi, I. (2026). GenReP: An Ensemble Model for Predicting TP53 in Response to Pharmaceutical Compounds. Molecules. https://doi.org/10.3390/molecules31040739

Vancouver

Spadaro A, Sharma A, Dehzangi I. GenReP: An Ensemble Model for Predicting TP53 in Response to Pharmaceutical Compounds. Molecules. 2026. doi:10.3390/molecules31040739

BibTeX
@article{Spadaro2026,
  author = {Spadaro, Austin and Sharma, Alok and Dehzangi, Iman},
  title = {GenReP: An Ensemble Model for Predicting TP53 in Response to Pharmaceutical Compounds},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31040739}
}
Kostenlos starten →